Justin M.  Miller net worth and biography

Justin Miller Biography and Net Worth

EVP of Avantor
Justin Miller is our Executive Vice President, General Counsel. In his current role, Mr. Miller leads our global Legal organization. Prior to assuming his current position, Mr. Miller served as an attorney at Ballard, Spahr, LLP, an American Lawyer top 100 firm. Mr. Miller also spent 20 years in various leadership positions at DuPont, most recently as Associate General Counsel and Chief Litigation Counsel. In addition to his background in securities and corporate governance, he has extensive commercial experience in pharmaceuticals, electronic materials, and biotechnology. Mr. Miller earned a bachelor’s degree in political science from University of Pennsylvania and a Juris Doctor degree from George Mason University School of Law in the United States.

What is Justin M. Miller's net worth?

The estimated net worth of Justin M. Miller is at least $2.21 million as of May 20th, 2021. Mr. Miller owns 86,536 shares of Avantor stock worth more than $2,210,995 as of March 28th. This net worth approximation does not reflect any other assets that Mr. Miller may own. Learn More about Justin M. Miller's net worth.

How do I contact Justin M. Miller?

The corporate mailing address for Mr. Miller and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at [email protected]. Learn More on Justin M. Miller's contact information.

Has Justin M. Miller been buying or selling shares of Avantor?

Justin M. Miller has not been actively trading shares of Avantor in the last ninety days. Most recently, Justin Miller sold 18,488 shares of the business's stock in a transaction on Thursday, May 20th. The shares were sold at an average price of $31.12, for a transaction totalling $575,346.56. Following the completion of the sale, the executive vice president now directly owns 86,536 shares of the company's stock, valued at $2,693,000.32. Learn More on Justin M. Miller's trading history.

Who are Avantor's active insiders?

Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (CEO), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.

Are insiders buying or selling shares of Avantor?

In the last twelve months, insiders at the sold shares 4 times. They sold a total of 40,278 shares worth more than $876,778.39. The most recent insider tranaction occured on February, 27th when EVP James Bramwell sold 6,203 shares worth more than $151,911.47. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.

Information on this page was last updated on 2/27/2024.

Justin M. Miller Insider Trading History at Avantor

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/20/2021Sell18,488$31.12$575,346.5686,536View SEC Filing Icon  
9/8/2020Sell22,887$21.17$484,517.79113,507View SEC Filing Icon  
See Full Table

Justin M. Miller Buying and Selling Activity at Avantor

This chart shows Justin Miller's buying and selling at Avantor by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avantor Company Overview

Avantor logo
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $25.55
Low: $25.52
High: $25.84

50 Day Range

MA: $24.14
Low: $21.56
High: $26.07

2 Week Range

Now: $25.55
Low: $16.63
High: $26.16

Volume

4,053,500 shs

Average Volume

6,128,999 shs

Market Capitalization

$17.33 billion

P/E Ratio

53.23

Dividend Yield

N/A

Beta

1.37